Stay in the know with VTCRC news & happenings. Sign up for our email list.

Feb 05, 2021

Tenant Spotlight: Landos Biopharma Announce Positive Results from a Phase 1 Study of NX-13 | VT Corporate Research Center

Feb 05, 2021

Tenant spotlight: Landos Biopharma Announces Pricing of Initial Public Offering

Jan 28, 2021

Tenant Spotlight: KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program

Jan 05, 2021

Tenant Spotlight: Precigen Announces Clearance of IND to Initiate Phase I Study | VT Corporate Research Center